Cardiomyocyte proliferation and regeneration in congenital heart disease

Jialiang Liang1, Xingyu He1, Yigang Wang1

  • 1Department of Pathology and Laboratory Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.

Pediatric Discovery
|September 23, 2024
PubMed

Insights

Congenital heart disease (CHD) treatments are improving, but new cardiac regenerative therapies focus on stimulating cardiomyocyte proliferation for better healing. Understanding genetic and epigenetic factors is key to developing novel treatments for CHD.

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Developmental Biology

Background:

  • Congenital heart disease (CHD) is the most common birth defect globally.
  • Current surgical treatments for CHD have limitations and can lead to complications.
  • Cardiac regenerative therapies offer a promising alternative for CHD treatment.

Purpose of the Study:

  • To review recent advancements in understanding the genetic and epigenetic mechanisms of defective cardiomyocyte proliferation in CHD.
  • To explore novel therapeutic strategies for stimulating cardiomyocyte proliferation and regeneration in CHD patients.

Main Methods:

  • Review of current literature on CHD, cardiomyocyte proliferation, and regenerative therapies.
  • Exploration of genetic and epigenetic factors influencing cardiomyocyte cell cycling.
  • Discussion of emerging technologies like human disease modeling, CRISPR editing, and next-generation sequencing.

Main Results:

  • Defective cardiomyocyte proliferation is a key issue in CHD, influenced by genetic and epigenetic factors.
  • Targeting cell cycle pathways presents a promising strategy for enhancing cardiomyocyte regeneration.
  • Advancements in technology are accelerating research into CHD mechanisms.

Conclusions:

  • Understanding the molecular mechanisms of cardiomyocyte proliferation in CHD is crucial for developing effective regenerative therapies.
  • Novel therapeutic approaches focusing on stimulating cardiomyocyte division and regeneration hold significant potential for improving CHD outcomes.
  • Future research integrating advanced technologies will pave the way for new CHD treatment paradigms.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Specialized Characteristics of Cardiac Muscles01:27

Specialized Characteristics of Cardiac Muscles

The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...
2.4K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
601
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
1.7K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K